Colistin resistance screening by 3 μg/ml colistin agar in Carbapenemase‐producing Enterobacterales

BACKGROUND: In low‐ and middle‐income countries, the use of colistin in therapeutic regimens is common, to treat infections produced for Carbapenemase‐producing Enterobacterales (CPE) due to limited access to the recently discovered‐approved antibiotics. Furthermore, the technical limitations to per...

Descripción completa

Detalles Bibliográficos
Autores principales: Soria‐Segarra, Claudia, Soria‐Segarra, Carmen, Andrade‐Soriano, Michelle, Quezada, Tamara Nuñez, Gestal, Monica C., Gutierrez‐Fernandez, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459281/
https://www.ncbi.nlm.nih.gov/pubmed/35944176
http://dx.doi.org/10.1002/jcla.24639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459281/
https://www.ncbi.nlm.nih.gov/pubmed/35944176
http://dx.doi.org/10.1002/jcla.24639

Ejemplares similares